Yuflyma
NDC 72606-023, adalimumab-aaty, kit, from CELLTRION USA, Inc..
- Product NDC
- 72606-023
- Status
- Listed
- Labeler
- CELLTRION USA, Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761219
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72606-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72606-023-04 | 72606002304 | 1 KIT in 1 CARTON (72606-023-04) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| 72606-023-07 | 72606002307 | 3 KIT in 1 CARTON (72606-023-07) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/526d626f-8c9f-496c-b838-00a73bb36383
Use it
Look up 72606-023 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72606-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72606-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.